Viewpoint Article Published in JAMA Internal Medicine: The Public Health Urgency of a Temporary FDA Moratorium on New Opioid Approvals
In a viewpoint article published in JAMA Internal Medicine, Public Citizen’s Dr. Sidney Wolfe explains why the Food and Drug Administration (FDA) should immediately impose a moratorium on approval of all new drug applications for new opioids or new opioid formulation until the agency has implemented the elements recommended by the National Academies of Sciences, Engineering, and Medicine for inclusion in the currently nonexistent opioid regulatory framework.
See Public Citizen’s other work on opioid drug issues.